Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
1 Jul 24
EFFECT
Notice of effectiveness
28 Jun 24
S-3
Shelf registration
18 Jun 24
DEFA14A
Additional proxy soliciting materials
3 Jun 24
8-K
Other Events
3 Jun 24
SD
Conflict minerals disclosure
29 May 24
ARS
2023 FY
Annual report to shareholders
21 May 24
DEFC14A
Proxy in contested solicitation
21 May 24
PRER14A
Preliminary revised proxy
20 May 24
PREC14A
Preliminary proxy with contested solicitation
10 May 24
10-Q
2024 Q3
Quarterly report
9 May 24
8-K
Standard BioTools Reports First Quarter 2024 Financial Results
8 May 24
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
8-K
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
25 Apr 24
8-K
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
18 Mar 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
S-3/A
Shelf registration (amended)
2 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
S-3
Shelf registration
19 Jan 24
S-3
Shelf registration
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
8-K/A
Financial Statements and Exhibits
19 Jan 24
8-K
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
8 Jan 24
8-K
Standard BioTools Stockholders Approve Merger with SomaLogic
5 Jan 24
425
Business combination disclosure
29 Dec 23
8-K
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
29 Dec 23
425
Business combination disclosure
22 Dec 23
8-K
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
22 Dec 23
424B3
Prospectus supplement
21 Dec 23
425
Business combination disclosure
19 Dec 23
8-K
Investor Presentation Unlocking Value in a Fragmented Space DECEMBER 2023
19 Dec 23
425
Business combination disclosure
4 Dec 23
8-K
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
4 Dec 23
Latest ownership filings
4
Eli Casdin
23 Jul 24
4
Frank Witney
2 Jul 24
4
Troy Cox
2 Jul 24
4
Eli Casdin
2 Jul 24
4
FENEL M ELOI
2 Jul 24
4
Thomas D. Carey
2 Jul 24
4
KATHY L HIBBS
2 Jul 24
3
Initial statement of insider ownership
26 Jun 24
144
Notice of proposed sale of securities
24 Jun 24
144
Notice of proposed sale of securities
24 Jun 24
144
Notice of proposed sale of securities
24 Jun 24
4
Eli Casdin
21 Jun 24
SC 13D/A
Casdin Capital, LLC
3 Jun 24
4
Eli Casdin
28 May 24
4
Eli Casdin
22 May 24
SC 13D/A
Casdin Capital, LLC
22 May 24
4
Michael Egholm
21 May 24
4
Jeffrey G. Black
21 May 24
4
Hanjoon Alex Kim
21 May 24
4
Eli Casdin
17 May 24
4
Jeffrey G. Black
16 May 24
4
Michael Egholm
9 Apr 24
4
Michael Egholm
5 Apr 24
4
Hanjoon Alex Kim
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
20 Mar 24
3
OLE ANDREAS HALVORSEN
20 Mar 24
4
Eli Casdin
20 Mar 24
SC 13D/A
Casdin Capital, LLC
20 Mar 24
144
Notice of proposed sale of securities
19 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Eli Casdin
6 Mar 24
SC 13G
MILLENNIUM MANAGEMENT LLC
26 Feb 24
4
Eli Casdin
22 Feb 24
SC 13G/A
Indaba Capital Management, L.P.
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13D/A
Neuberger Berman Group LLC
12 Jan 24
4
Change in insider ownership
9 Jan 24